v3.26.1
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Preferred Stock
Additional paid-in capital
Accumulated deficit
Total
Balance at Dec. 31, 2024 $ 4   $ 462,358 $ (390,343) $ 72,019
Balance (in shares) at Dec. 31, 2024 1,919,420 49,585      
Balance (in shares) at Jun. 30, 2025 2,273,748 53,440      
Deemed dividend related to issuance of preferred Stock     8,807 (8,807)  
Conversion of Preferred Stock to Common Stock (in shares) 83,403 (2,945)      
Exercise of pre-funded warrant to common stock     1,750   1,750
Exercise of pre-funded warrant to common stock (in shares) 142,985        
Stock-based compensation     4,377   4,377
Stock-based compensation (in shares) 127,940        
Issuance of preferred stock, net of issuance cost     6,815   6,815
Issuance of preferred stock, net of issuance cost (in shares)   6,800      
Issuance of warrants in connection with Callodine Loan Facility, net of issuance cost     1,140   1,140
Modification of former lender warrants     102   102
Modification of preferred stock     1,604 (1,604)  
Net loss       (22,217) (22,217)
Balance at Jun. 30, 2025 $ 4   486,953 (422,971) 63,986
Balance (in shares) at Dec. 31, 2024 1,919,420 49,585      
Balance (in shares) at Jun. 30, 2025 2,273,748 53,440      
Balance at Mar. 31, 2025 $ 4   478,104 (404,409) 73,699
Balance (in shares) at Mar. 31, 2025 2,135,330 54,585      
Balance (in shares) at Jun. 30, 2025 2,273,748 53,440      
Deemed dividend related to issuance of preferred Stock     3,968 (3,968)  
Conversion of Preferred Stock to Common Stock (in shares) 40,632 (1,145)      
Stock-based compensation     2,035   2,035
Stock-based compensation (in shares) 97,786        
Issuance of warrants in connection with Callodine Loan Facility, net of issuance cost     1,140   1,140
Modification of former lender warrants     102   102
Modification of preferred stock     1,604 (1,604)  
Net loss       (12,990) (12,990)
Balance at Jun. 30, 2025 $ 4   486,953 (422,971) 63,986
Balance (in shares) at Mar. 31, 2025 2,135,330 54,585      
Balance (in shares) at Jun. 30, 2025 2,273,748 53,440      
Balance at Dec. 31, 2025 $ 4   519,996 (452,078) 67,922
Balance (in shares) at Dec. 31, 2025 6,905,948        
Balance (in shares) at Jun. 30, 2026 7,341,866        
Issuance of common stock related to lock up agreement (in shares) 204,851        
Issuance of common stock, net of issuance cost (in shares) 14,191        
Exercise of pre-funded warrant to common stock     1,266   1,266
Exercise of pre-funded warrant to common stock (in shares) 186,998        
Stock-based compensation     2,073   2,073
Stock-based compensation (in shares) 29,878        
Net loss       (16,173) (16,173)
Balance at Jun. 30, 2026 $ 4   523,335 (468,251) 55,088
Balance (in shares) at Dec. 31, 2025 6,905,948        
Balance (in shares) at Jun. 30, 2026 7,341,866        
Balance at Mar. 31, 2026 $ 4   522,703 (460,327) 62,380
Balance (in shares) at Mar. 31, 2026 7,299,026        
Balance (in shares) at Jun. 30, 2026 7,341,866        
Issuance of common stock, net of issuance cost (in shares) 14,191        
Stock-based compensation     632   632
Stock-based compensation (in shares) 28,649        
Net loss       (7,924) (7,924)
Balance at Jun. 30, 2026 $ 4   $ 523,335 $ (468,251) $ 55,088
Balance (in shares) at Mar. 31, 2026 7,299,026        
Balance (in shares) at Jun. 30, 2026 7,341,866